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Bacterial surface proteins can be good vaccine candidates. In the present study, we
used polyclonal antibodies purified with intact Erysipelothrix rhusiopthiae to screen
phage-displayed random dodecapeptide and loop-constrained heptapeptide libraries,
which led to the identification of mimotopes. Homology search of the mimotope
sequences against E. rhusiopthiae-encoded ORF sequences revealed 14 new antigens
that may localize on the surface of E. rhusiopthiae. When these putative surface proteins
were used to immunize mice, 9/11 antigens induced protective immunity. Thus, we have
demonstrated that a combination of using the whole bacterial cells to purify antibodies
and using the phage-displayed peptide libraries to determine the antigen specificities of
the antibodies can lead to the discovery of novel bacterial surface antigens. This can be
a general approach for identifying surface antigens for other bacterial species.
Keywords: phage display, mimotope, homology analysis, subcellular localization, surface protein, Erysipelothrix
rhusiopthiae
INTRODUCTION
Bacterial surface proteins play an essential role in bacterial interactions with the environment,
including cell-cell interactions, ion and nutrient transport, cell signaling, and antibiotic resistance;
they are also important for host cell infection, and specifically for defense against host responses and
induction of toxicity (Niemann et al., 2004; Lebeer et al., 2010; Schneewind and Missiakas, 2012;
Chagnot et al., 2013). Given their direct interaction with the host immune system, some bacterial
surface proteins are candidates for vaccine development. Vaccines based on bacterial surface
and secreted molecules are already commercially available, such as Infanrix (GlaxoSmithKline
Biologicals S.A., Belgium), meningococcal group B vaccine (Pfizer, USA), and pneumococcal
polysaccharide conjugate vaccine (Pfizer), with many others still under development (Rodríguez-
Ortega et al., 2006; Jores et al., 2009; He and De Buck, 2010; Gomez et al., 2013; Sun et al.,
2014).
There are currently two approaches to identifying surface proteins for vaccine development.
One is reverse vaccinology, which is used in silico and for high-throughput screening of the
entire genome of a pathogen to identify genes encoding protective antigens. This has enabled the
discovery of protective antigens against Meningococcus (Pizza et al., 2000), group A Streptococcus
(Mora et al., 2005), and Streptococcus pneumoniae (Hava and Camilli, 2002). However, this method
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is time consuming and requires complex genomic analyses
(Jones, 2012). Alternatively, bacterial surface proteins have
been identified by a proteomics approach, including those
in Mycoplasma mycoides (Jores et al., 2009), Mycobacterium
smegmatis (He and De Buck, 2010), and Streptococcus suis
serotype 2 (Geng et al., 2008). But, the steps required for surface
protein separation and peptide pretreatment are inconvenient
and labor intensive, and the presence of cytoplasmic proteins or
peptides may affect reproducibility (Emerson et al., 2008).
Phage display is a powerful molecular technique for the
rapid identification of pathogen mimotopes from anti-bacterial
antibodies (Pande et al., 2010); corresponding antigens can be
identified by homology analysis of mimotopes covering the entire
bacterial genome. However, in practice it is difficult to identify
antigens based solely on mimotopes, since homology analysis of
short input sequences using the Basic Local Alignment Search
Tool (BLAST) can yield hundreds of homologous proteins.
Surface proteins represent only a fraction of all bacterial proteins;
as such, they can be identified by searching a subcellular
localization database (Yu et al., 2006; Chou and Shen, 2010; Yu
et al., 2010).
To demonstrate the feasibility of the phage display-subcellular
localization approach for identifying protective surface proteins,
we selected Erysipelothrix rhusiopthiae as a model pathogen. E.
rhusiopathiae causes swine erysipelas but has also been detected
in other species, including humans (Reboli and Farrar, 1989).
Swine erysipelas is distributed worldwide and has economic
importance (Wang et al., 2010; Zou et al., 2015). Traditional
inactivated and attenuated vaccines are effective in preventing
E. rhusiopathiae infection, but can also fail (Imada et al., 2004;
Eamens et al., 2006; Bender et al., 2010); subunit vaccines based
on surface-exposed proteins represent a potential alternative.
However, there are major hurdles in the development of
erysipelas vaccines—including a lack of knowledge regarding
its pathogenesis—and only a few surface proteins have been
identified in E. rhusiopathiae, such as surface protective antigen,
E. rhusiopathiae surface proteins A and C, and choline-binding
protein (Shimoji et al., 2003; Ogawa et al., 2011; Shi et al.,
2013; Uchiyama et al., 2014). The present study was carried
out in order to identify bacterial surface protective proteins
by screening peptide phage libraries using whole bacterial
cell-purified antisera.
MATERIALS AND METHODS
Bacterial Strains and Antisera
E. rhusiopathiae strain (ML10.1, 16sRNA GenBank: KC661000)
was isolated from a pig farm in Hunan province, China. The
bacteria were incubated in tryptic-soytone-broth (TSB, Sigma)
medium + 10% rabbit serum at 37◦C. Eight 4-week old pigs
were immunized with inactivated vaccine of E. rhusiopathiae by
intramuscularly injection (5 × 1010 colony forming units/pig).
After 4 weeks, the pigs were challenged intramuscularly with 3
× 107 colony forming units (CFU) of E. rhusiopathiae. Fifteen
days later, auricular vein antisera samples were collected, pooled,
and used for purification of antibodies against surface proteins
of E. rhusiopathiae. Two sera from E. rhusiopathiae negative pigs
but immunized with inactivated vaccine of Pasteurella multocida
(gram negative bacterium) were selected as negative control.
The animal experiment was performed with the approval of the
Review Committee for the Use of Animal Subjects of Hunan
Agricultural University and all experimental protocols were
performed according to the ARRIVE guidelines of the National
Institutes of Health guide for the care and use of Laboratory
animals (NIH Publications No. 8023, revised 1978).
Affinity Purification of Polyclonal
Antibodies against E. rhusiopathiae
Pooled antisera of E. rhusiopathiae were used for antibody
purification. E. rhusiopathiae was grown overnight in TSB 10%
rabbit serum. The cells were adjusted to 1013 CFU, and then
suspended in 5 ml antisera for 10 min at ambient temperature
to permit adsorption of polyclonal antibodies. Following low-
speed centrifugation the pellets were resuspended and washed 3x
in TBST (50 mM Tris, 150 mM NaCl, pH 7.5, containing 0.5%
Tween-20), and then resuspended in 1 ml 0.2 M glycine-HCl (pH
2.2) for 10 min to dissociate the adsorbed antibodies. Following
removal of the bacteria by centrifugation, the pH of the antibody-
containing supernatant was neutralized with 150 µl 1 M Tris-
HCl, pH 9.1. Finally, the antibodies were purified by recombinant
Staphylococcus Protein A (SPA) affinity chromatography (Pierce,
USA), according to the manufacturer’s instructions. Specificity,
purity, and concentration of the purified polyclonal antibodies
were checked by ELISA kit (CIVTEST SUIS SE/MR, Hipra,
Spain), SDS-PAGE, and BCA Protein Assay Kit (Pierce, USA),
respectively. Negative control sera were purified as the same
method.
Phage Display Library and Biopanning of
Binding Peptides
The purified polyclonal antibodies were applied for biopanning
of mimotopes of E. rhusiopathiae by using linear random library
Ph.D.TM-12 and loop-constrained random library Ph.D.-C7C
(New England Biolabs, USA). For the first round of biopanning, a
well of a 96-well ELISA plate was coated with 1µg antibodies and
blocked with 0.5% BSA for 1 h. Next, 5 µl of the library [5× 1010
plaque forming unit (pfu)] with 95 µl of TBST (Tween-20, 0.1%)
was added and the plate was rocked gently for 30 min at ambient
temperature. Following washing 10x with TBST (Tween-20,
0.1%), any bound phage remaining were eluted with 100 µl
0.2 M glycine-HCl, pH 2.2 (eluting buffer). After neutralization
with 15 µl 1 M Tris-HCl (pH 9.1), a 2 µl aliquot of the eluted
phage suspension was taken for titering and the remainder
was amplified in E. coli ER2738 for 4.5 h. After high-speed
centrifugation, the supernatant was purified by precipitation with
20% PEG8000/2.5 M NaCl. Subsequently, the amplified phages
were titered and used for the second biopanning.
Solution-phase panning by the affinity SPA Sepharose capture
method was applied for second round biopanning as follows: the
amplified phage was adjusted to 5× 1010 pfu in TBST (Tween-20,
0.3%) and mixed with 0.5 µg antibodies. Following incubation
for 20 min at ambient temperature, the phage-antibody mixture
was added to 50 µl SPA Sepharose (Pierce, USA), and incubated
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for 15 min. Following washing 10x with TBST (Tween-20, 0.3%)
and centrifugation, the adsorbed phages were eluted. Phages
selected in this round were then titrated and amplified. The third
round procedure was similar to the first, except that the Tween-20
concentration was adjusted to 0.5% (v/v).
Selection of Mimotopes by Phage-ELISA
Phage plaques from the third round screening of each of the two
phage libraries were randomly picked and amplified for ELISA as
following: polyclonal antibodies were coated onto an ELISA plate
(1 µg/well) and blocked with 0.5% BSA for 1 h. Purified phage
clones, each containing 5 × 1010 phages, were added to the plate
and incubated for 2 h at ambient temperature. After 6 washes
with TBST (Tween-20, 0.5%), horseradish peroxidase (HRP)-
conjugated anti-M13 monoclonal antibody (GE Healthcare,
USA) was added and incubation was continued at ambient
temperature for 1 h. Following an additional 6 washes with TBST,
50 µl TMB (Sigma, USA) was added, the plate was incubated for
10 min at 37◦C, and then 50 µl 2 M sulfuric acid was added.
OD450 was measured using a microplate reader (MK3; Thermo
Labsystem, Finland). An absorbance value≥2.1× the mean value
of a negative control (M13KE, vector phage without a displayed
peptide) was considered positive.
DNA Sequencing and Mimotope Homology
Search against Bacteria-Encoded Open
Reading Frame (ORF)
After phage-ELISA detection, 100 positive phages were selected
from each library for DNA sequencing (Genscript, Nanjing,
China); the obtained sequences were analyzed as follows. First,
mimotopes were searched in the SAROTUP database (http://
immunet.cn/sarotup) to exclude target-unrelated peptides
(TUPs; Huang et al., 2010). The Clustal Omega program (http://
www.ebi.ac.uk/Tools/msa/clustalo/) was used for multiple-
sequence alignment to identify core residues of the mimotopes.
The peptides were then searched by BLASTP and PHI-BLAST in
National Center for Biotechnology Information E. rhusiopathiae-
encoded ORF database [Erysipelothrix (taxid:1647)]. Proteins
with high similarity to each mimotope were selected for
subcellular localization prediction.
Surface Proteins Identification by
Subcellular Localization Prediction
The subcellular localization of proteins selected from the
homology analysis of each mimotope was determined by
searching the Cell-Ploc (http://www.csbio.sjtu.edu.cn/bioinf/
Cell-PLoc), PSORTb (http://www.psort.org), and CELLO (http://
cello.life.nctu.edu.tw) databases (Yu et al., 2006; Chou and Shen,
2010; Yu et al., 2010). Proteins that were identified as being
located on the cell surface in at least two websites and that
met the following conditions were selected as candidate surface
antigens of E. rhusiopathiae: those showing high similarity to the
mimotopes (≥ five continuous amino acid residues) or lower
similarity to the mimotopes (≥ three but < five continuous
amino acid residues; Vendruscolo et al., 2001) were evaluated for
surface probability using Protean software, with corresponding
amino acids showing the characteristics of functional epitopes
determined based on the surface probability plot (DNASTAR,
Madison, WI, USA).
Cloning and Expression of the Selected
Surface Proteins
Fourteen new proteins were defined and selected for cloning and
expression in E. coli. The target sequence of the Fujisawa and
SY1027 strains, available from GenBank (accession: AB019124
and CP005079), were used for primer design. The corresponding
genes containing possible epitope regions (Table 1) were cloned
in the pET-28a (+) vector (Novagen, Madison, WI, USA),
and the recombinant proteins were expressed in E. coli
BL21 (DE3). The oligonucleotide primers used to amplify
the relevant DNA fragments from the template DNA of E.
rhusiopathiae strain ML10.1 are listed in Table 2. Following
expression in E. coli, soluble recombinant proteins were purified
using a His-Bind Purification kit (Novagen) according to the
manufacturer’s instructions. Purity and concentration of the
proteins were determined by SDS-PAGE and BCA Protein Assay
Kit, respectively. Inclusion bodies were first dissolved in 8 M
urea and purified by the same method as the proteins expressed
in the supernatant. All recombinant proteins were used for the
following immunization trial.
Immunogenicity of Recombinant Proteins
Female Institute of Cancer Research mice (3 weeks old)
were immunized by subcutaneous injection with one of 11
recombinant proteins adsorbed to an aluminum-containing
adjuvant (Brenntag Biosector, Fredrikssund, Denmark; 20
µg/mouse). After 2 weeks, the mice received a booster of the
same recombinant protein with adjuvant. TBS and inactivated
E. rhusiopathiae (5 × 107 CFU/mouse) were used as negative
and positive controls, respectively. Tail vein blood samples
were collected before the first injection and every 14 days post
injection, and serum antibody titers were determined by ELISA
using recombinant proteins as antigens. Results were considered
as positive if the OD450 of the positive relative to the negative
control was >2.1. Two weeks after the boost immunization,
the mice were challenged by intraperitoneal injection of 300
CFU of E. rhusiopathiae, and mortality was monitored for the
following 14 days. The animal research was performed with
the approval of the Review Committee for the Use of Animal
Subjects of Hunan Agricultural University and all experimental
protocols were performed according to the ARRIVE guidelines
of the National Institutes of Health guide for the care and
use of Laboratory animals (NIH Publications No. 8023, revised
1978). Survival profiles were plotted for each infected group
and analyzed with the log-rank/Mantel-Cox test using GraphPad
Prism 5 software (GraphPad Inc., La Jolla, CA, USA).
Whole-Cell ELISA and Immunoblotting
Sera from mice immunized with the recombinant proteins
were used to detect interactions with whole bacteria by whole-
cell ELISA. A 96-well microtiter plate was coated with 107
bacteria per well and adsorbed antibodies were detected as
previously described (Pizza et al., 2000). Each assay was
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TABLE 1 | Homologous protein alignment analysis of mimotopes with E. rhusiopathiae in NCBI and subcellular localization prediction.
Mimotope Possible epitope region Sequencing
proportion (%)
Possible surface protein
aHINWPILPRLWV 48 PILPRI 53 12 Spa (Surface protective antigen, accession BAE93265, BAE93266, ALJ77816,
ABR27208, etc.)aSPDHASRDWRSR 446 SPDH 449 5
bMSLLTAT 14 MSCLLLTA 21 3
bDLKSTVK 395 DLESLVK 401 2
aTQLDDHKRSHHA 865 TQLD 868 10 RspA (rhusiopathiae surface protein A, accession BAK31725)
a ISRPTPSVNPLM 1936 RPTKPSVPPL 1945 1
aLTQGTSDMTRHL 651 LTQQTS 656 1
bNNWLTMP 99 TIKLTMP 105 2
bNTVRESV 1152 VRESGV 1157 2
aSWKPYTWKDTAL 1347 YTWKN 1351 1 RspC (rhusiopathiae surface protein C, accession BAK32739)
aFQGSPKTNHGKI 1032 SPKT 1035 1
aGPTFNLQRIPAT 1144 TFNLYQI 1150 1
bVSRYNWG 1027 VNRYQS 1032 1
bSHNQPYQ 786 NQPY789 1
bLQAKPRT 458 QAKP 461 1
aQTKSSVYMMSYL 258 SVYLQSY 264 5 CwpA (LPXTG-motif cell wall anchor domain protein, accession BAK32481)
bLSKWTTS 948 WTTS 951 2
bLNANTSL 226 NANTAL231 2
bSPNYSRN 794 SPNYVSKN 801 2
aWHSNNSHNDSWP 349 NNTHDD354 1 Plp (Pectin lyase fold-containing protein, accession BAK31224)
aADKPRVDTTTYN 1465 ADKP 1468 1
bNADKPTE 1465 ADKPTD 1469 6
bERTNSSD 421 NSSD 424 1
bQPSRDTY 399 SRDT 402 1
a IRLPASLLLDPA 1245 PTSLVLD 1251 3 CbpA (Collagen-binding protein, accession BAK31134)
bYGDSNLA 78 DSNL81 2
bGQEGMKE 1325 GQDGM 1329 2
aGPKSNNVGVTYS 746 PKSN 749 4 Gh (Glycoside hydrolase, family 85, accession BAK31618)
bNAMLRAV 237 NAMLR 241 1
bLPFMIHN 965 PFMIKN 970 1
aFWPHKHNLYMST 363 PHKGNL 368 2 CbpB (Choline-binding protein, accession BAK31823)
b ILSDSGS 113 ILSDS 117 2
bPTVKQKW 511 IKQKW 515 2
aAHWFGGVYNKTM 128 FGGVY 132 1 Bga (Beta-galactosidase, accession BAK31835)
aTPLPSPIDITYQ 1320 PSLLDITYE 1328 1
aYALHDGTAHNTW 826 AQHDGT 831 1
bSSATLVY 538 SSAT541 1
aLQASAKTMHGTI 185 LQEGAKSMNKTI196 3 Bml (Basic membrane lipoprotein, accession BAK32060)
bGAKWMSQ 188 GAKSM 192 2
aSNTYLPKSYLNV 433 NIYLKKS439 1 Neu (Neuraminidase, accession BAK31357)
bRDKALVN 698 DKALI 702 1
bNTTQSVM 712 NTTQ715 1
bSTSFDNS 579 TSYDN 583 1
aAHRYIDAQIDRR 191 AQIDR 195 1 CwpB (LPXTG-motif cell wall anchor domain protein, accession BAK32507)
bLALDRRD 191 AQIDR 195 1
bYRPTTDQ 399 YRPTTD 401 1
aSMLRQEFPPTEP 262 DFPPT 266 1 Hp (alpha/beta hydrolase domain-containing protein, accession)
bLKTLNPS 196 TLNPS 200 1
aQTHHHTFFMKSK 274 HHSNFMSNK 282 1 CbpC (Collagen-binding protein, accession BAK32489)
bQYRNHAD 950 RNQAD 954 1
(Continued)
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TABLE 1 | Continued
Mimotope Possible epitope region Sequencing
proportion (%)
Possible surface protein
aYYYADDGAILLN 556 FYFADD 561 2 Da (Dipeptidyl aminopeptidase, accession BAK31118)
bSFPKNLD 45 PKNLD 49 1 Atsp (ABC transporter, substrate-binding protein, accession BAK31287)
bFQPKRLD 45 PKNLD 49 1
bSSSGQRL 1136 SSGERL1141 1 Hya (Hyaluronidase, accession BAK31820)
bYRENHSY 1293 RQNHS 1297 1
b ILNYPES 931 YPES 934 1 Pca (peptidase M14, carboxypeptidase A, accession BAK31220)
bQEGTNKA 1012 TNKA 1015 1
a12-peptides screened from random library Ph.D.TM-12.
b7-peptides screened from random library Ph.D.-C7C; underlined sequences: may be the core residues and used for PHI-BLAST (performs the search but limits alignments to those
core residues in the query); red font: may be the epitope region of the protein according to homologous protein alignment analysis of mimotope; red italic font: showing lower similarity
to the mimotope but identified as a possible functional epitope by Protean software (surface probability analysis, DNAStar, Inc. Madison, WI).
performed in duplicate. The surface exposure of the identified
proteins was determined by immunoblotting, with swine
polyclonal antibodies (prepared by affinity-purifying polyclonal
antibodies against E. rhusiopathiae) against surface proteins of E.
rhusiopathiae used as the primary antibody.
RESULTS
Serum Preparation and Polyclonal
Antibody Purification
Eight antisera of E. rhusiopathiae derived from vaccine-
immunized and bacterially challenged pigs were pooled and
used for antibody purification. Highly pure polyclonal antibodies
against E. rhusiopathiae surface molecules were obtained
(antibody titers are shown in Supplementary Table 1; no
antibodies were obtained from the negative control), as
determined by SDS-PAGE (Figure 1). The concentration of the
purified antibodies was 240 µg/ml, as determined by the BCA
protein assay, indicating that the purification procedure was
effective.
Phage Display and Sequence Analysis
Affinity purified polyclonal antibodies were used for phage
display. After three rounds of biopanning, clones from each
phage library were randomly selected and detected by phage-
ELISA. Each phage library was selected 100 positive phages
for DNA sequencing. A total of 36 separate 12-peptide and 65
separate 7-peptide mimotopes were obtained and no TUPs were
found (data not shown). A bioinformatics analysis revealed 23
12-peptide and 34 7-peptide sequences showing high similarity
to 18 surface proteins of E. rhusiopathiae (Table 1), of which 14
were targeted by both libraries. In particular, LQASAKTMHGTI
and GAKWMSQ, ADKPRVDTTTYN and NADKPTE, and
AHRYIDAQIDRR and LALDRRD showed high similarity in the
same amino acid regions (i.e., possible epitopes) of Bml, Plp,
and CwpB respectively (Table 1). Moreover, Spa, RspA, CbpB,
and RspC—which are E. rhusiopathiae surface proteins (Shimoji
et al., 2003; Ogawa et al., 2011; Shi et al., 2013; Uchiyama et al.,
2014)—were also identified, although RspC is not a protective
antigen.
TABLE 2 | PCR primers used for cloning of recombinant proteins.
Primer
name
Primer sequence (5′–3′) Target
position
CwpA Fp CGCGGATCC GGGCTAGATGTTGATACTGATTTT 692–941aa
CwpA Rp CCGCTCGAG ATTACCTGATGCATCAAATCTTTC
Plp Fp CGCGGATCC TTTTCCATCGATCGTGAGAATGG 862–1500aa
Plp Rp ACGCGTCGAC TTCAAATTTTGATTGTACACCCG
CbpA Fp CGCGGATCC ACAACAGATGAAAAACTATCAGGT 26–350aa
CbpA Rp CCGCTCGAG TGGTGCTTTGGTCTCATTCCAAC
Bga Fp CGCGGATCC TCATATAAAGCAATCCGTGCAAAAC 519–936aa
Bga Rp CGCGTCGAC TACGCTAAATGATCCAGGTTGTTC
BML Fp GGAGAATTC ATGTCAAAGTCAACGGAAGATCAAAAG 20–362aa
BML Rp TGTCGAC GCGATAATAATCGATTTTTAGAT
Neu Fp CGCGGATCC AAAGGGAATACACAAGTAGAAGGTC 837–1156aa
Neu Rp CGCGTCGAC TGGATCTACGATTGGAGGTGTG
CwpB Fp CCCAAGCTT TGGGTTACTAAAGCACAAATTGAT 186–539aa
CwpB Rp CCGCTCGAG TCCTTCAAACCACGCATCAACAC
Da Fp CGCGGATCC GCTAAGAAACACATGGCATTTATTAA 23–635aa
Da Rp CGCGTCGAC AGTACGTGAAAGATCATGGTTTTC
Atsp Fp CGCGGATCC ACTGATAAACCAGAGGGAGAAG 26–481aa
Atsp Rp CCGCTCGAG TTTACTTGCTTGGAATGCATCGA
Hya Fp CGCGGATCC ATGCCACATCAACGACTTGAATC 818–1509aa
Hya Rp ACGCGTCGAC CATGTCTTGAGCACGACCTG
Pca Fp CGCGGATCC GGCGCAGAAGCAGATATCTTCC 602–1174aa
Pca Rp CCGCTCGAG TTTTTTCTTTTTTGAGAACCAGTAG
Underlined sequences: restriction enzyme cutting sites. Recombinant proteins, Gh, CbpC,
and Hp, were not successfully expressed and the corresponding primers are not listed.
The CwpA, Plp, CbpA, Bga, and Neu genes code for multi-fragment expression, but only
the fragment of each with the highest antigenicity is shown.
Cloning and Expression of Selected
Proteins and Their Immunogenicity
Analysis in Mice
Of the 14 new proteins, CwpA, Plp, CbpA, Gh, Bga, Bml, Neu,
CwpB, Hp, CbpC, Da, Atsp, Hya, and Pca, were selected and the
corresponding genes were expressed in E. coliBL21 (DE3). Eleven
proteins were obtained (SDS-PAGE see Supplementary Figure 1),
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FIGURE 1 | SDS-PAGE analysis of E. rhusiopthiae polyclonal antibody
with or without β-mercaptoethanol. M, protein marker; 1, negative control;
2, polyclonal antibodies against E. rhusiopthiae before purified by recombinant
Staphylococcus Protein A affinity chromatography; 3, polyclonal antibodies
against E. rhusiopthiae in reductive (β-mercaptoethanol) SDS-PAGE after
complete purification; 4, BSA (250 µg/ml); 5, polyclonal antibodies against E.
rhusiopthiae in non-reductive SDS-PAGE after complete purification.
including 8 inclusion bodies (Plp, CbpA, Bga, Neu, CwpB, Da,
Hya, and Pca) and 3 soluble recombinant proteins (CwpA, Bml,
and Atsp). However, three of the recombinant proteins (Gh, Hp,
and CbpC) were not expressed in E. coli. The immunogenicity
of the recombinants was evaluated by immunization; all of the
mice developed high titers of antibody against each protein (see
Supplementary Table 2).
The LD50 of E. rhusiopathiae for mice was approximately
10 CFU; 300 CFU of bacteria were intraperitoneally injected
into each mouse 14 days after boost immunization. In the Hya,
Pca, and negative control groups, some mice developed clinical
signs such as reduced activity, awkward movement, huddled
posture, or ocular discharge and started to die on day 2 after the
challenge. Somemice in the other groups—except for the positive
controls—exhibited clinical symptoms on day 3 and started to die
on day 4. Nine of the recombinant proteins provided protection
against E. rhusiopathiae (P < 0.0001), with a survival rate of 10–
20% among mice treated with CwpA, Neu, Atsp, Plp, or CwpB
and a survival rate of 40% among those treated with Bga or Da
(Figure 2). Mice in the Hya, Pca, and negative control groups
all died by day 5, whereas those treated with Bml or CbpA
died on day 7 after challenge; these deaths were significantly
delayed relative to controls (P < 0.0001). Two of 10 mice in the
inactivated vaccine group also died (see Supplementary Figures
2, 3, Supplementary Tables 3, 4).
Surface-Exposed Analysis by Whole-Cell
ELISA and Immunoblotting
To determine if the identified proteins are E. rhusiopathiae
surface proteins, sera against each recombinant were tested by
FIGURE 2 | Protection of mice against E. rhusiopathiae by the
recombinant proteins. N, negative control (TBS); P, positive control
(inactivated vaccine of E. rhusiopathiae). Recombinant proteins, adsorbed to
an aluminum-containing adjuvant, were used to immunize 3-week old female
Institute of Cancer Research (ICR) mice by subcutaneous injection (20
µg/mouse). After 2 weeks, the mice received a booster of the same
recombinant proteins with adjuvant. TBS and inactivated vaccine of E.
rhusiopathiae (5 × 107 CFU/mouse) were used as negative and positive
controls, respectively. Two weeks after the last immunization, the mice were
intraperitoneally challenged with 300 CFU of E. rhusiopathiae, and the
mortalities were monitored for the following 14 days. Survival profiles were
plotted for each infected group and analyzed with the log-rank/Mantel-Cox
test using GraphPad Prism 5 software, p < 0.0001.
FIGURE 3 | Serum antibodies of recombinant proteins against E.
rhusiopathiae as determined by whole-cell ELISA. 1, Bga; 2, Hya; 3, Da;
4, Plp; 5, Bml; 6, Atsp; 7, Neu; 8, CbpA; 9, Pca; 10, CwpA; 11, CwpB; P,
Positive control; N, Negative control. The error bars represent standard
deviation of the mean from two independent experiments.
whole-cell ELISA. All serum antibodies against the recombinants
were positive by ELISA, with anti-Hya and -CwpB antibodies
present at high OD450 values, and anti-Pca, -Bml, -Atsp, and
-Da antibodies present at low OD450 (Figure 3). To evaluate
the surface exposure of each protein in vivo, we performed
immunoblotting of the 11 recombinant proteins using swine
polyclonal antibodies against E. rhusiopathiae surface molecules.
The results showed that apart from Pca, Bml and Atsp
all recombinant proteins stimulated a strong immunogenic
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FIGURE 4 | Recombinant proteins of E. rhusiopathiae analyzed by
western blots. Purified swine IgG against surface molecules of E.
rhusiopathiae was used as the primary antibody. M, protein marker; three
images are grouped together.
reaction (Figure 4, full-length gels and blots can be found as
Supplementary Figure 3).
DISCUSSION
To obtain polyclonal antibodies against only the surface
molecules of bacteria, antisera were mixed with whole E.
rhusiopathiae cells to allow the adsorption of target antibodies
onto the bacterial surface; the antibodies were then affinity
purified (Figure 1). A key aspect of the new approach reported
here is the high efficiency with which surface proteins can
be identified according to bacterial mimotopes. In theory,
mimotopes screened using whole bacterial cell-purified antisera
can be used to identify the corresponding antigen genes through
a homology search of the bacterial genome. However, this
is challenging in practice since hundreds of proteins can be
identified by homology analysis (BLAST search) of the short
mimotope input sequences. For instance, when the 12-peptide
mimotope HINWPILPRLWV was searched against the full E.
rhusiopathiae genome, more than 70 homologous proteins were
listed. However, by applying the subcellular localization criterion,
surface proteins can be specifically detected.
Solid- and solution-phase panning procedures as well as
linear and conformational phage libraries were alternately
applied to detect appropriate mimotopes. About 64% (23/36)
of 12-peptides and 53% (34/65) of 7-peptides are linked
to a surface protein, with 14/18 found by both phage
libraries. In particular, LQASAKTMHGTI, GAKWMSQ,
ADKPRVDTTTYN, NADKPTE, AHRYIDAQIDRR, and
LALDRRD showed high similarity to the same amino acid
regions within Bml, Plp, and CwpB (Table 1), indicating that our
biopanning approach was effective. However, it should be noted
that mimotopes cannot be used to find all native surface proteins
of E. rhusiopathiae, since some may mimic polysaccharides and
lipids that are also detected by affinity selection (Neu, 1996;
Srivastava et al., 2000).
Of a total of 18 surface proteins screened, Spa—which is a
major protective antigen of E. rhusiopathiae—had the highest
proportion of screening hits (17% for 12-peptides and 5% for
7-peptides; Table 1). Other reported surface protective antigens
including RspA and CbpB (Shimoji et al., 2003; Shi et al., 2013;
Uchiyama et al., 2014)—which were detected by both libraries—
also showed a high proportion of hits. RspC (with a proportion
of screening hits of 3% in both libraries) was also identified as a
surface protein of E. rhusiopathiae, although not as a protective
antigen (Ogawa et al., 2011). In addition, nine new protective
antigens with 7 were identified by both phage libraries. These
results demonstrate that this is a highly effective procedure for
protective antigen screening.
Reverse vaccinology and proteomics technologies have been
used to identify protective bacterial antigens. The former was
first applied to the identification of seven meningococcal surface
protective antigens from among 350 candidates during an 18-
month period (Pizza et al., 2000). Protective antigens have also
been screened from a variety of surface proteins using a cell wall
proteomics approach. For example, six protective antigens were
identified from among 114 surface proteins of S. pneumoniae
(Olaya-Abril et al., 2012), and 14 were identified from among
75 surface proteins of group A Streptococcus, but with a low
screening efficiency (<20%; Rodríguez-Ortega et al., 2006). The
efficiency can be improved by immunoproteomics; nonetheless,
cell wall separation and pretreatment steps required in these
procedures are labor intensive (Emerson et al., 2008). In our
approach, three previously reported and nine new protective
antigens were identified from among 11 proteins within a 6-
month period, with a screening efficiency >80%. In addition,
our approach is uncomplicated and requires no specialized
instrumentation, thus saving time and cost.
We evaluated immunogenicity and surface exposure of
selected proteins in the test bacterium. We found that Hya is
a highly expressed surface-exposed protein in E. rhusiopathiae
(Figures 3, 4), but is not a protective antigen for reasons that are
unclear. Of the nine identified protective antigens, the discovery
of Bga and Da is surprising, since both are thought to be
involved in metabolic regulation. Bga plays an important role
in lactose metabolism and is released by bacteria, although S.
pneumonia Bga may function in pathogenesis rather than in
lactose enzymolysis (Zähner and Hakenbeck, 2000). In our study,
E. rhusiopathiae Bga protected 40% of mice against infection;
however, given its high similarity to S. pneumonia Bga it may also
be involved in E. rhusiopathiae pathogenesis.
Aminopeptidases are involved in the synthesis and
degradation of physiological components of bacteria, including
in post-translational modification, signal peptide cutting,
and proenzyme activation (Jankiewicz and Bielawski, 2003).
Our results revealed that the aminopeptidase Da conferred
protection to 40% of mice against bacterial challenge and may
present a higher surface-exposed in vivo relative to in vitro
(Figures 3, 4), suggesting that the antibody induced by Da plays
an important role in immune protection against E. rhusiopathiae.
These findings suggest that our approach can provide novel
insights in functional studies of bacterial surface protective
antigens.
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We have described a new approach for identifying bacterial
protective antigens by screening peptide phage libraries using
whole bacterial cell-purified antisera with an efficiency of up to
80%. This enables the rapid discovery of protective antigens with
manageable amounts of biopanning and bioinformatics analysis
while providing insights into the functions of bacterial surface
antigens. Protective antigens of strain D P. multocida (a Gram-
negative species) were also screened in this manner, and the
results confirmed the high efficiency of this method (unpublished
work in our laboratory). Application of this approach to other
pathogens may promote the discovery and improve functional
analyses of candidate surface proteins against infectious diseases.
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